​
​

Cue Biopharma (CUE) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Cue Biopharma Revenue Highlights

Latest Revenue (Y)

$5.49M

Latest Revenue (Q)

$3.34M

Cue Biopharma Revenue by Period

Cue Biopharma Revenue by Year

DateRevenueChange
2023-12-31-340.88%
2022-12-31--91.67%
2021-12-31-373.68%
2020-12-31--8.78%
2019-12-31-202.64%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31--

Cue Biopharma generated $5.49M in revenue during NA 2023, up 340.88% compared to the previous quarter, and up 480.48% compared to the same period a year ago.

Cue Biopharma Revenue by Quarter

DateRevenueChange
2024-09-30-25.51%
2024-06-30-54.80%
2024-03-31--5.71%
2023-12-31--13.29%
2023-09-30-51.95%
2023-06-30-639.04%
2023-03-31-23.66%
2022-12-31-122.39%
2022-09-30-161.54%
2022-06-30--97.40%
2022-03-31--87.89%
2021-12-31-244.65%
2021-09-30--12.56%
2021-06-30-76.37%
2021-03-31-226.72%
2020-12-31--32.48%
2020-09-30--34.51%
2020-06-30-19.44%
2020-03-31--14.20%
2019-12-31-6.61%
2019-09-30--6.73%
2019-06-30-185.14%
2019-03-31-11.92%
2018-12-31--26.37%
2018-09-30-161.05%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30--

Cue Biopharma generated $3.34M in revenue during Q3 2024, up 25.51% compared to the previous quarter, and up 241.39% compared to the same period a year ago.

Cue Biopharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
FENCFennec Pharmaceuticals--
TCRXTScan Therapeutics--
HOOKHOOKIPA Pharma--
COYACoya Therapeutics--
CUECue Biopharma--
TFFPTFF Pharmaceuticals--
ANIXAnixa Biosciences--
XFORX4 Pharmaceuticals--
DAWNDay One Biopharmaceuticals--
INABIN8bio--
CGTXCognition Therapeutics--
ELYMEliem Therapeutics--
TERNTerns Pharmaceuticals--
DRMADermata Therapeutics--
PYPDPolyPid--
LTRNLantern Pharma--
INMBINmune Bio--

CUE Revenue FAQ

What is Cue Biopharma’s yearly revenue?

Cue Biopharma's yearly revenue for 2023 was $5.49M, representing an increase of 340.88% compared to 2022. The company's yearly revenue for 2022 was $1.25M, representing a decrease of -91.67% compared to 2021. CUE's yearly revenue for 2021 was $14.94M, representing an increase of 373.68% compared to 2020.

What is Cue Biopharma’s quarterly revenue?

Cue Biopharma's quarterly revenue for Q3 2024 was $3.34M, a 25.51% increase from the previous quarter (Q2 2024), and a 58.86% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $2.66M, a 54.80% increase from the previous quarter (Q1 2024), and a 92.33% increase year-over-year (Q2 2023). CUE's quarterly revenue for Q1 2024 was $1.72M, a -5.71% decrease from the previous quarter (Q4 2023), and a 818.18% increase year-over-year (Q1 2023).

What is Cue Biopharma’s revenue growth rate?

Cue Biopharma's revenue growth rate for the last 3 years (2021-2023) was -63.26%, and for the last 5 years (2019-2023) was 58.76%.